$12.5 million Capital Raised by Medical Device Manufacturer, NICO Corporation

NICO Corporation, a leader in modern interventional technologies and a medical device provider in Indianapolis has announced that it has completed a capital raise of $12.5 million of Series B. As stated by the company, the funding is raised among present shareholders which would provide resources for their lined-up priority activities including commercialization, new product development, additional biological preservation and tissue collection clinical studies, growth of clinical and sales team, regional expansion, and adding to the ever-growing published evidence library around enhanced economic and clinical outcomes

Jim Pearson, President and CEO of NICO Corporation stated that the company’s shareholders have confirmed and substantiated the confidence and commitment in the outcomes and value of NCIO technologies as well as their capabilities to create and grow new markets in neurosurgery. Market growth in neurosurgery is challenging owing to the environment that is changing slowly along with the era of strict healthcare protocols and regulations, and it only happens via documented outcomes that demonstrate improved economic value and clinical outcomes. Jim further added that the capital infusion positions NICO to additionally validate and support clinical outcomes through publications peer-reviewed and enables the company to company to keep working towards addressing the growing demand across the globe for the NICO technologies utilized in minimally invasive parafascicular surgery (MIPS).

The company focuses on extending its capabilities across various geographies and presently has its footprint in Australia, United Kingdom, the United States, Singapore and Canada. The primary focal point of expansion for the company remains Europe where NICO plans to offer its medical solutions.

NICO Corporation stated in their press release that the neurosurgery device market is expected to showcase rapid growth over the forthcoming decade owing to continuously expanding capabilities of neurosurgery by hospitals to align with advanced imaging, approach, and technological integration with the help of MIPS. NICO Corporation is determined to introduce products continuously for meeting the clinical needs and foster clinical evidence for the purpose of research activities. This funding would play a major role in the company’s future pursuits and initiatives. Ever since NICO Corporation has been found, the company has managed to raise $49.5 million in capital funding.

Such funding raised by key players in the healthcare industry and their clear objective to enhance their offerings and expand their reach is expected to foster the developments in healthcare while opening new doors of opportunities for the companies to serve patients better

The Arrival of 5G Smartphones is Expected to Push Back Leading Players in the Market

Currently, as market leader, Samsung holds around 20 percent of the worldwide smartphone market, followed by Huawei and Apple at around 14 and 13 per cent respectively during the third quarter of this year.

Giants Fall to Technology Transition

Earlier, when the telecommunications industry moved from 2G, 3G and to 4G, a number of major smartphone market players lost significant amounts of market share owing to challenges rising from design innovations to keep up with technological advancements.

The biggest example of this was the fall of Finland-based Nokia which was a market leader during the period of 2G, and lost significant traction during 3G, and almost completely faded away during the era of 4G. The company was unable to keep up with new advances such as dual-sim capabilities. Despite the acquisition of the company by Microsoft, the business had to stop.

Similarly, Motorola also lost significant market share during the move from 2G to 3G. While Samsung was the biggest gainer during the 3G period, with an increase of double the market share, the company is anticipated to face a tough time with 5G, as China is anticipated to be one of the major markets for the new technology, with Chinese smartphone manufacturers taking center stage.

In addition, Huawei is also anticipated to face a challenging time during the period of transition, owing to the blockage of the company’s smartphone and 5G business within the United States.

Expected Winners of the 5G Battle

Small scale players including Sony, and Sharp are anticipated to gain market share in the local markets, provided they display agility in brand marketing and technology building. On the other hand, brands such as OPPO, Vivo, and Xiaomi, are anticipated to gain market share on a global scale, with the enhancement of distribution and marketing networks, leading to profitable sales of several million units. All of these companies already have a strong network in Asia and Europe and are anticipated to put forth strong competition in North and South America during the 5G phase.

At a time, when consumers are unwilling to pay high amounts on new phones which show only small improvements, the intense competition between smartphone manufacturers will largely come down to who has the wider portfolio of useful intellectual property.

Market players such as Lenovo-Motorola and LG will require smart strategizing to transition successfully in to 5G or risk heavy losses, While Samsung and Huawei, will face challenges owing to their limited presence in the China and US markets.

Fox Network Group and AT&T to Renew the Multi-year Deal

The American multinational telecommunications company AT&T and the television company, Fox Network Group announced the renewal of their multi-year deal which establishes the continuation of distribution of Fox programming across the video platforms of AT&T including DIRECTV NOW, DIRECTV, and AT&T U-verse.

The local broadcast stations in 17 cities and regional sports networks owned by the Fox Network Group are included in the renewal. The renewal also includes the National Geographic Channel, FS1, FS2, Nat Geo Wild, FX, FXM, FXX, and Spanish Language services such as Nat Geo Mundo, Fox Deportes and Fox Life, BabyTV, along with Fox Soccer Plus pay-per-view service.

The chief content officer and senior executive vice president for AT&T Communications, Daniel York said that they are pleased to close the multi-year deal with Fox Network Group for the complete range of content of AT&T. He further added that the customers of AT&T communications would continue to enjoy their programming on-demand and live on a range of devices. The customers can enjoy the same in both on-the-go and at home. Daniel concluded, saying that they have been working with FOX Network Group for delivering greater choices for customers and providing enhanced value to them.

Although the financial terms are undisclosed this deal reflects the increasing emphasis given to customers and their needs for which the communication companies thrive harder for offering immense alternatives and choices which could effectively improve offerings for the customers.

President of Distribution, Fox Network Group, Mike Biard, said that the expanded partnership of FOX Network Group with AT&T through the extended range of agreement ensures that that the highly rated sports and entertainment programming would be available on a broader level to the customers of DIRECTNOW, DirecTV, and U-Verse for the forthcoming years.

With increasing partnerships such as this, the entertainment industry and communications sector is expected to benefit largely. The increasing spending witnessed over these segments by the customers across the globe is expected to foster the growth in the sector. The Fox Network Group and AT&T’s partnership over renewing the multi-year deal highlights their joint strategic business offerings as they head towards providing customers the right programming along with the flexibility of streaming at home or right into their mobile devices when they commute. The long-term deal between these two giants would bring effective transformations to the sector.

CSIRO Aims for Artificial Intelligence and Space Technology Advancements with $35M Increase in Funding

The top science and space agency of Australia announced a massive $35 million investment into space technology and artificial intelligence, which is anticipated to act as a significant part of the state run science and space agency’s portfolio for the Future Science Platforms, which was initiated by the organization during 2016.

Investment to Develop Solutions for Real-world Problems

A large chunk of the $35 million investment will be spent on developing machine learning and artificial intelligence capabilities, to improve understanding and predictions on complex information build upon solutions for global issues of high importance including sustainable energy production, environment protection, and food security among others.

$16 million will be pressed into development of advancements in space technology that will primarily be used for the observation of the earth, efficient utilization of resources in space, manufacturing equipment for Mars and Moon missions, improving life support systems, alongside the accurate tracking of interstellar objects. The activities will also involve the employment of post-doctoral researchers and students, and a number of collaborations within the industry.

Apart from artificial intelligence, machine learning, and new space technology CSIRO’s future science platforms portfolio also includes modules such as environomics, precision health, synthetic biology, active integrated matter, probing bio-systems, digiscape, hydrogen energy systems, and deep earth imaging. For instance, the initiative made automotive hydrogen powered systems work through hydrogen extracted from ammonia.

Australian Space Agency Projected to Triple in Size

The $16 million investment combined with the $26 million from the federal budget earlier this year, will be key to the formation of a dedicated Australian Space Agency. This move is anticipated to grow the size of the Australian space sector by three times to $20 billion by the year 2030. The researchers at CSIRO are also currently researching laser technology that is touted to bring about a revolution in how data is captured from space. The process is anticipated to increase data capture by up to 10 times through the use of optics and light instead of radio waves.

The Future Science Platform is anticipated to utilize the challenging environment of Australia to opportunities for scientific growth that will put the country on center-stage on a global scale, by bringing the best expertise in regards to technology, science, math, and engineering. This will be able to develop innovative solutions for problems for various regions around the world, giving Australia an edge in the market.

Nestle To Grab Consumer Nutrition Business of GlaxoSmithKline in India

Some of the biggest consumer companies across the globe have been eyeing on the nutrition business of GlaxoSmithKline and the competition has been intensifying for securing the expensive Horlicks malted drink product of the company. Amongst other products, malt-based drinks are considered as one of the largest health-food drink across India.

Nestle is pitted against Unilever in the final talk of negotiations for acquiring GSK’s Indian consumer nutrition business, which is inclusive of Horlicks malted drink product. Nestle has been taking the lead with a significantly huge offer by leaving Unilever behind and Coca-Cola being the third contender has been opted out. The winner will be launching an open offer for mopping up nearly 26% additional stake.

Earlier this year, GlaxoSmithKline had mentioned about a strategic review with regards to its nutrition business across the globe and this review is likely to conclude by 2018-end. The transaction is highly beneficial for the FMCG bounty hunters who are seeking for expansion opportunities in India.

Nestle India to Widen Malt Drink Product Portfolio

Nestle India has been selling malt drink Milo and is now seeking for expansion of its product portfolio with acquisition of Horlicks brand by GSK. This in turn helps the company in synergizing distribution of Milo by means of pharmacy channels. Growing demand from parents to fill the nutritional gaps of their children has influenced Nestle in firming up on Horlicks brand acquisition. Local manufacturers are ramping up on their product offerings in order to attract newcomers such as the Manpasand Beverages, a juice-drink maker.

GSK Introduces New Version of Horlicks

GlaxoSmithKline lately introduced a new version of Horlicks with addition of protein for competing in the explosion of ayurvedic products and energy drinks. GSK is strongly focusing on innovation and launch of sachets, which in turn would benefit in recouping growth. However, the decision of parent market to place Horlicks on block by carrying out the strategic analysis of its heavy investment in GSK of India is a threat.

GSK has been planning to continue making heavy investments for intensifying growth opportunities for its oral health and over-the-counter brands in India such as Eno and Sensodyne. The company has been constantly investing in vaccines and pharmaceutical businesses with development of new manufacturing plant in Vemgal, Karnataka. Understanding millennial preferences, employing new acquisition strategies and leveraging new packaging techniques is turning to be play an essential role in the competitive business world.

Aquaculture Meets IoT: A Unison That Would Transform the Fish Farming Industry

One of the most-traded food commodities worldwide is, Fish with developing nations exporting the most of fish to the rest of the world. According to representatives and experts from the food industry, the oceans and inland waters exhibit colossal window of opportunity- even more in the coming future- contributing to food security and adequate nutrition of the growing population worldwide. Aquaculture is the “breeding, rearing, and harvesting of animals and plants in all types of water environments.” Experts believe that aquaculture is one of the most efficient and sustainable ways to produce protein- thereby, catering to nutrition needs and food security in many parts of the world. According to National Oceanic and Atmospheric Association (NOAA Fisheries) a US government body responsible for studying, analysis, and protecting the nation’s ocean resources and their habitat, in 2014 alone, the value of the aquaculture market was US$160 billion.

Fish produced from aquaculture is mostly meant for human consumption, however, the by-products are used for non-food purposes. The global aquaculture market is predominantly dominated by Asia (89 percent), with China accounting for almost 62 percent, followed by India, Vietnam, Bangladesh, and Egypt. Leeching on the opportunity, “startups in seafood and aquaculture technology, raised US$193 million in 2016, a 271% increase on the US$52 million raised across both 2014 and 2015”, according to Agfunder, a leading platform for accredited investors looking to invest in curated food and agriculture technology companies. Additionally, the ‘2030 Agenda’ adopted by United Nations member states in 2015,  “sets aims for the contribution and conduct of fisheries and aquaculture towards food security and nutrition in the use of natural resources so as to ensure sustainable development in economic, social and environmental terms.”

This brings us to the next part. What more can be done to enhance and improve aquaculture production? Enter Internet of Things (IoT) that has taken the world by storm. Established players and startups are leveraging the power of IoT to develop technologies that pulls data from various sensors and satellites. The massive data recovered from such sensors is put to use to make aquaculture operations more efficient and eco-friendly using cloud-based analytic software tools.

Predictive Software, Cloud-Platforms, and Counting Fish Larvae among More IoT Technologies to Drive Aquaculture

Predictive Platform for Shrimps: Recently, Cargill, a key player in the aquaculture market, launched a predictive software platform that uses machine learning to help farmers manage risks and make better decisions in shrimp farming. Experts believe that this platform will help the shrimp farming industry as shrimps are often exposed to disease and weather risks. Data such as shrimp size, health, quality of water, feeding patterns and weather conditions can be collected by farmers using mobile devices, sensors and, automated feeders. The farmers then make sense of the data using algorithms and make informed decisions regarding feeding strategies and favorable harvest dates. Using IoT-enabled sensors and software, an Indonesian startup is helping shrimps farms to monitor water quality. Conditions like dissolved oxygen, temperature, humidity, pH, salinity and total dissolved solids is measured by this all-in-one device and the data is instantly accessible on a smartphone application. Employing specific algorithms, the data is then used for making corrective actions.

Weather Predicting Technology for Oysters: The Yield is an IoT-powered platform made especially for oyster farming industry uses sensors to collect climate-related data like water temperature and depth, salinity, barometric pressure in the water and sea-tide height- which is then used for a three- day weather prediction on harvesting conditions.

Fish Counting Made Easy: A Canada-based aquaculture-focused startup launched a technology empowered by AI and computer vision to better control fish inventories in fish farms and hatcheries. This IoT-enabled device helps in counting shrimp larvae. The device named XperCount- that allows people one person to count up to five bags of larvae in about 25 minutes, is connected to a portal where consumers can access data and analytics related to counting in the fisheries and hatcheries.

Watching Fish Behavior: An IoT device that runs on solar energy using sensors and machine learning to detect fish behavior and if the fish is ready to be fed was added to the aquaculture industry. Experts believe that the device named UmiGarden is important when it comes chances exercising caution interms of overfeeding. The device uses computer-vision technology for facial recognition to study fish behavior. Additionally, UmiGarden also uses satellite imagery resources to leverage data about environmental conditions, which might affect fish behavior including water temperature. Additionally, Indonesia-based eFishery launched a smartphone-controlled automatic fish feeder that uses sensors to track hungry fish. Experts believe that hungry fish become aggressive creating more turbulence and ripples in the water- sending a signal to the sensors.

IoT for Deep Ocean Research: Scientific agency NOAA and other research institutions have been collectively studying Deep Ocean life through various offshore ranches. NOAA and other research institutions use Navy Oceanographic Meteorological Automatic Device (NOMAD) that helps them to collect and transmit diverse oceanographic data. This data is then used for assessing environmental footprint and optimize farming operations accordingly. An addition to this facility, a device named Cytobot was introduced- enabled with microscope and machine vision that detects harmful algae growth in deep ocean.

What’s next? 

Considering that the consumption of fish is on an all-time rise, fish farming is witnessing an overhaul worldwide and exploring ways to make it more efficient and fruitful in terms of breeding and quality and quantum of production. From using artificial intelligence for monitoring and behavioral analysis of species to machine learning for analytics and predictive modeling, the fish farming sector is continually leveraging the power of IoT. Additionally, mergers and acquisitions will further solidify the IoT trend in aquaculture boosting the market further.

Environment Concerns and Government Emphasis on Renewable Energy to Drive Solar Invertor Sales

With growing importance being given to alternative energy sources to solve the issue of climate change and rapid development of new technologies in the field, the solar energy sector is gaining high priority in both commercial and residential purposes. New government led initiatives and awareness about the effects of environmental pollution are expected to push up the demand for solar inverters worldwide.

Government Initiatives for Developing Green Technologies Show Their Effect

The solar inverter market is showing good signs for the future, because growing need of solar power worldwide, to supplement the inadequate power production through conventional means is gaining importance. Recent times have also produced various developments in the field. Massive monetary investments in the renewable energy industry has propelled the solar energy manufacturer’s activities. For instance, investments in by Australian public sector is expected to rise by more than double in the near future.

In a similar manner, Dubai’s public energy sector has gone into a collaboration with energy companies of the region to boost solar power production capacities of the region by a significant amount. The project which will cost more than 13 billion dollars is expected to increase adoption of solar inverters in the near future for the country.

Electronics in solar inverters are expected to develop on the basis of specific modules and will see increased demand because of low installation and maintenance efforts and costs, coupled with high rates of production for solar power.

Market players are increasingly developing solar inverters with better durability in addition to long-duration warrantees to buyers up to 25 years. Therefore adoption of solar inverters is anticipated to grow rapidly in the years to come.

On the other hand, growing competition in the sector resulting in lowered prices will reduce earnings of solar inverter manufacturers which will restrain the solar inverter market in the years to come.

Efficiency-Boosting Technological Innovations Gain Significance

Numerous manufacturers operating in the solar inverter market are emphasizing on activities involving research to enhance solar inverter performance and better repair, overhaul, and maintenance services by using tech improvements.

Some of the key players in the solar inverter manufacturing sector such as Schneider Electric Co., Emerson Electric Company, Power-one Inc., KACO New Energy Inc., and SMA Solar Technology AG are working on such innovations.

Moreover, these companies are also emphasizing on boosted capacity for producing solar inverters, to fulfil present and future demand. Bonfiglioli for example, has noticeably raised its production capacity by more than 100 per cent in the past few years.

For example, SolarEdge has also released a wide range of new solar inverter products that make use of optimized power gauges for efficient consumption tracking and power flow management. The inverter can easily change from using DC to AC as a result, which makes sure of correct operation in different conditions. In addition, compact solar inverters that are ideal for restricted roof space are also being developed.

For similar use, Sungrow has released solar inverters that utilize single switching transistors that are capable of dealing with a very wide spectrum of voltages in comparison to traditional inverters that despite using multiple transistors are unable to use more than one voltage.

A 3 phase inverter has also been developed by Siemens maintains a fixed level of voltage in spite of multiple changes in the modules or the surrounding environment. The information on the running of such inverters can also studied with a basic internet access for improved troubleshooting processes.

An assessment of the global solar inverter market provides a full write up of the future and present situations in the solar inverter market. The report on the solar inverter market allows the gathering of useful insights to be available for readers.

Robotics to help aid in autism in children

Research experts at the UAE University have come across impressive findings, which state that the robot teachers are substantially effective high-tech tools for boosting the attention levels of children diagnosed with autism. The academics at UAEU College of Informations Technology have ascertained that by leveraging the capabilities of artificial intelligence it is possible to assist future developments in healthcare as children are likely to devote exceeding attention towards robots than they would to any human.

According to researchers, children suffering from autism gave a better response to simple instructions provided by robots as found in the research study. The research further indicated that the learning of children, however, was usually hindered with the intricate ideas by a human face.

Dr. Fady Al Najjar, assistant professor at the UAEU College stated that complex behaviors presented to autistic children would not be accepted by them and the children would try avoiding an eye contact. This would inhibit their learning owing to which their team tried to solve this complexity with the introduction of a robot that presents limited behaviors and lesser physical complexities. He further added that their idea is to present robots to children while a medical professional would add commands behind the scenes. Such an activity would enable them to control the amount of information passed through the robot on to the child from the teacher or doctors.

For this research, the team at UAE University made use of a specific testing with robots. The children were introduced to several screen characters to gauge their response on them.

The research team at the University aims to build an interaction enabled with artificial intelligence between the children and robots so that the machine could learn the commands that are gaining greater attention and response from the child. With this development, doctor’s inputs are likely to reduce enabling them to monitor instead of inputting commands to stimulate and trigger attention from autistic children. Artificial intelligence is not just simplifying tasks for teachers dealing with autistic children but is expected to bring major transformations in the future.

As technology enables several developments in key areas of growth, robotics is gaining increasing significance owing to the endless possibilities that come along with it. The capabilities of robotics and technology are expected to foster the future capabilities of medical treatment and learning. This would enable healthcare professionals to gain effective assistance for complex medical treatment procedures in the foreseeable future.

AHEL to Diversify Its Pharmacy Business

AHEL (Apollo Hospitals Enterprise Ltd) has planned to restructure its business exercise by divesting its pharmacy business by forming it as a separate entity and naming it as APL (Apollo Pharmacies Ltd). The newly formed company will turn out to be a completely owned subsidiary of AMPL (Apollo Medicals Pvt Ltd). Apollo management has mentioned that the new entity is just front-end division of the pharmacy business, which is valued at nearly Rs.5.27Bn.

New investors have taken up on nearly 75% stake for approximately 1.06Bn in Apollo Medicals Pvt Ltd, while parent company, the Apollo Hospitals has been planning to pull up nearly 25% stake in AMPL. The new investors are inclusive of Enam Securities, Jhelum Investment Fund, DSP BlackRock’s chairman and investment banker Hemendra Kothari and these investors will be owning the remaining 75%.

Proposed Reorganization to Beef up Pharmacy Retail Business

Apollo has been taking immense efforts in unlocking the potential of its pharmacy business by sharply focusing on retail sector as well. The company further is planning to enter into e-commerce zone that is basically its omni-network strategy for providing consumers with an option for picking up on physical or online stores. In the forthcoming years, according to Shobana Kamineni, AHEL’s executive vice-chairperson, the company will be looking for new or strategic equity investors, while IPO remains a choice to be explored.

The company had clearly stated that the proposed reorganization will not be holding back any material impact on AHEL’s financials as backend business that is related with the pharmacy business inhibits nearly 85% of business economics, which will be help by AHEL in future as well. The propose move will be highly beneficial for Apollo as it will comply with prescribed FDI (foreign direct investment) limits, which in turn helps in further expanding pharmacy retail business. Apollo is expecting the new organization to be operative by April 2019. Apollo had mentioned that this spin-off will enable the company in maximizing stakeholder value as well as set platform for the ‘value discovery’ pharmacy retail business.

Pharmacy Division Sales Growth: Consolidated Information

The pharmacy business consisted of nearly 38% of Apollo’s Rs.8, 243.5Cr revenues in the FY18. Pharmacy business has increased by 17% on Y-o-Y basis with 4.5% EBITDA margin, which is comparatively lesser than company’s EBITDA of 9.6%. Organized pharmacy retail holds less than 5% of $15Bn domestic pharmaceutical market of India, which is likely to increase by 12% CAGR by over the next 10year time-span that would be predominantly driven by volume growth.

The company has been currently experiencing nearly 27% growth in business with improved operational performance of flagship hospital business. The merged EBITDA rose at 11.3%, while the hospital business EBITDA rose at 18.2%. New hospitals revenue growth increased by 23% with majority revenue share from Tamil Nadu, which consisted of Rs.979.8Cr. Shares of Apollo has increased by 1.82% for closing at Rs.11, 66.15 on BSE.

Forward Looking Plans

Shobana Kamineni has been focusing on creating a multi-year development platform with the expansion of pharmacy outlets to be nearly 5,000 from current 3,167 in the next 5years and is also anticipating a turnover of Rs.100Bn revenue. She further stated that approximately 20% revenue growth would be from the online segment. In addition, Apollo is planning to enhance its private label business to over 12%. Apollo will be entering into brand licensing contract with the APL for licensing Apollo Pharmacy to online pharmacy operations and frontend stores.

Spin-offs have outperformed broadly in the business world with increasing unique investment opportunities expected to take place. By spinning-off pharmacy business, AMPL can remove debt from balance sheet, thereby improving its total margin levels, which in turn becomes valuable for investors.

US-based Avenue Therapeutics to be Acquired for $215 Mn by Cipla Subsidiary

Cipla, the leading player in the global drug market announced that its subsidiary InvaGen had entered into formal agreement to acquire US-based specialty pharmaceutical company Avenue Therapeutics from Fortress Biotech for approximately $215 Mn (Rs. 15.6 Bn). The acquisition is anticipated to take place in two phases.

As stated by Cipla in a regulatory filing, at the closing of the first stage, InvaGen and its affiliates will acquire a 33.3% stake in Avenue Therapeutics’ capital stock, through the issuance of new shares by Avenue on a completely diluted basis for $35 Mn. This activity will involve 5,833,333 common stock shares at a price of $6 per share.

At the same time, with the closing of the issuance of stock, InvaGen and its affiliates will put forth the appointment of 3 members into the 7-member board of directors of Avenue Therapeutics, one of which will be independent. During this second stage activity, InvaGen will acquire the remaining shares of Avenue Therapeutics for a further $180 Mn in total, or $13.92 per share.

Avenue Therapeutics has so far been largely known for the development and commercialization of its proprietary intravenous (IV) painkiller, Tramadol.

The transaction will go through after a number of closing conditions including the approvals from the shareholders of Avenue Therapeutics and regulatory bodies are met satisfactorily. The deal will be financed with the help of a dollar based loan in the United States, putting Cipla on an even footing with industry counterparts such as Sun Pharma and Dr. Reddy’s who already have an established presence in the country.

Cipla, in its statement said that the closing of the second stage of acquisition will be subject to a number of conditions including US Food and Drug Adminsitration approval for labelling and scheduling along with the absence of restrictions such as Risk Evaluation and Mitigation Strategy on Avenue Therapeutics’ IV Tramadol medication.

A spokesperson from Cipla stated that the acquisition deal is anticipated to put Cipla squarely in the lucrative sector of specialty institutional businesses across therapeutic areas present in the US, and to build a dedicated distribution network in specialty products in the US market. The deal also puts Cipla in position to present solutions for the major problem of opioid abuse in the region.

Shares of Cipla were trading at a lower rate of approximately 0.69 per cent at Rs. 528.2 each at the Bombay Stock Exchange.